Analyzing normetabolites of the fentanyls by gas chromatography/electron capture detection

Journal of Analytical Toxicology

Volumn 12, Issue 4, 1988, Pages 183-191

  Hammargren, W R ^a,b   Henderson, G L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DROPERIDOL; DROPERIDOL PLUS FENTANYL; DRUG METABOLITE; FENTANYL; FENTANYL CITRATE;

GAS LIQUID CHROMATOGRAPHY; HUMAN; METHODOLOGY; URINE;

CHROMATOGRAPHY, GAS; FENTANYL; HUMAN; MASS FRAGMENTOGRAPHY; RADIOIMMUNOASSAY; SUPPORT, NON-U.S. GOV'T;

EID: 0023687093     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/12.4.183     Document Type: Article

References (50)

1. P.A.J. Janssen. U.S. Patent 3164600, 1965.
2. J.S. Finch and T.J. DeKorneld. Clinical investigation of the analgesic potency and respiratory depressant activity of fentanyl, a new narcotic analgesic. J. Clin. Pharmacol. 7: 46-51 (1967).
3. F.I. Grell, R.A. Koons, and J.S. Denson. Fentanyl in anesthesia: A report of 500 cases. Anesth. Analg. 49: 523-32 (1970).
4. J.F. Gardocki and J. Yelnosky. A study of some of the pharmacologic actions of fentanyl citrate. Toxicol. Appl. Pharmacol. 6: 48-62 (1964).
5. R.S. Reneman, G.J. van der Vusse, R. Xhanneux, and W. van Gerven. The use of high doses of analgesics during anesthesia- A general review. In Analgesia in Anesthesia and Obstetrics, Proceedings Boerhaave Course. Leiden, Belgium, 1979, pp. 35-52.
6. A Fentanyl Family of Analgesics: Sufentanil, Alfentanil, and Lofentanil, Investigators brochure. Janssen Pharmaceutica, Beerse, Belgium, 1981.
7. P.A.J. Janssen. Potent, new analgesics, tailor-made for different purposes. Acta Anaesthesiol. Scand. 26: 262-68 (1982).
8. T.C. Kram, D.A. Cooper, and A.C. Allen. Behind the identification of China White. Anal. Chem. 53: 1379-86 (1981).
9. G.L. Henderson. Blood concentrations of fentanyl and its analogs in overdose victims. Proc. Soc. West. Pharm. 26: 287-90 (1983).
10. R. Baum. Designer drugs: Underground chemists ply a deadly trade. Chem. Eng. News. 9: 7-16 (1985).
11. G.L. Henderson. Designer drugs: Past history and future prospects. J. Forensic Sci. 33: 569-75 (1988).
12. H.D. Silsby, D.J. Kruzich, and M.R. Hawkins. Fentanyl citrate abuse among health care professionals. Mil. Med. 149: 227-28 (1984).
13. W.F.M. Van Bever, C.J.E. Niemegeers, and P.A.J. Janssen. Synthetic Analgesics. Synthesis and pharmacology of the diastereomers of A/-[3-methyl-1-(2-phenylethyi)-4-piperidyl]-A/-phenylpropanamide and N-[3-methyl-1-(1-methyl-2-phenethyl)-4-piperidyl]-/V-phenylpropanamide. J. Med. Chem. 17: 1047-51 (1974).
14. R. Hess, A. Herz, and K. Fridel. Pharmacokinetics of fentanyl in rabbits in view of the importance for limiting the effect. J. Pharmacol. Exp. Ther. 179: 474-84 (1971).
15. R. Hess, G. Stiebler, and A. Herz. Pharmacokinetics of fentanyl in man and the rabbit. Eur. J. Clin. Pharmacol. 4:137-41 (1972).
16. R. Schleimer, E. Benjamini, J. Eisele, and G. Henderson. Pharmacokinetics of fentanyl as determined by radioimmunoassay. Clin. Pharmacol. Ther. 23: 188-94 (1978).
17. D.A. McClain and C.C. Hug. Intravenous fentanyl kinetics. Clin. Pharmacol. Ther. 28: 106-14 (1980).
18. C. Hug and M. Murphy. Tissue redistribution of fentanyl and termination of its effects in rats. Anesthesiology 55:369-75 (1981).
19. I. Van Wijngaarden and W. Soudjin. The metabolism and excretion of the analgesic fentanyl (R 4263) by Wistar rats. Life Sci. 7: 1239-44 (1968).
20. Y. Maruyama and E. Hosaya. Studies of the fate of fentanyl. Keio J. Med. 18: 59-70 (1969).
21. H. Van Rooy, M. Vermeulen, and J. Bovill. The assay of fentanyl and its metabolites in plasma of patients using gas chromatography with alkali flame ionization detection and gas chromatography-mass spectrometry. J. Chromatogr. 223: 85-93 (1981).
22. K. Lehmann, G. Moseler, and D. Daub. Biotransformation von fentanyl; I. In-vitro Abbau druch Gewebe der Maus. Anaesthetist 30: 461-466 (1981).
23. T. Goromaru, H. Matsuura, T. Furuta, S. Baba, N. Yoshima, T. Miyawaki, and T. Samashima. Identification of fentanyl metabolites in rat urine by gas chromatography-mass spectrometry with stable-isotope tracers. Drug Metab. Dispos. 10: 542-46 (1982).
24. K. Lehmann, C. Weski, C. Hug, and D. Daub. Biotransformation von Fentanyl; II. Akute Arzneimittelinteraktionen-Untersuchung bei Ratte und Mensch. Anaesthetist 31: 221-27 (1982).
25. T. Goromaru, H. Matsuura, N. Yoshima, T. Miyawaki, T. Sameshima, J. Miyao, T. Furuta, and S. Baba. Identification and quantitative determination of fentanyl metabolites in patients by gas chromatography-mass spectrometry. Anesthesiology 61: 73-77 (1984).
26. J.M. Frincke and G.L. Henderson. The major metabolite of fentanyl in the horse. Drug Metab. Dispos. 8: 425-27 (1981).
27. W. Meuldermans, R. Hurkmans, and J. Heykants. Plasma protein binding and distribution of fentanyl, alfentanil and lofentanil in blood. Arch. Int. Pharmacodyn. Ther. 257: 4-19 (1982).
28. F. Camu, E. Gepts, M. Rucquoi, and J. Heykants. Pharmacokinetics of alfentanil in man. Anesth. Analg. 61: 657-61 (1982).
29. G.L. Henderson, J. Frinke, C.Y. Leung, M. Torten, and E. Benjamini. Antibodies to fentanyl. J. Pharmacol. Exp. Ther. 192: 489-96 (1975).
30. R. Schleimer, E. Benjamini, J. Eisele, and G.L. Henderson. Pharmacokinetics of fentanyl as determined by radioimmunoassay. Clin. Pharmacol. Ther. 23: 188-94 (1978).
31. W.E. Woods, H.H. Tai, C. Tai, T. Weckman, T. Wood, H. Barios, J.W. Blake, and T. Tobin. High-sensitivity radioimmunoassay screening method for fentanyl. Am. J. Vet. Res. 10: 2180-83 (1986).
32. S.-N. Lin, T.-RF. Wang, R.M. Caprioli, and B.P.N. Mo. Determination of plasma fentanyl by GC-mass spectrometry and pharmacokinetic analysis. J. Pharm. Sci. 70: 1276-79 (1981).
33. R. Woestenborghs, L. Michielsen, and J. Heykants. Rapid and sensitive gas chromatographic method for the determination of alfentanil and sufentanil in biological samples. J. Chromatogr. 224: 122-27 (1981).
34. T.J. Gillespie, A.J. Gandolfi, TP. Davis, and R.A. Morano. Identification and quantification of a-methylfentanyl in postmortem specimens. J. Anal. Toxicol. 6: 139-42 (1982).
35. J.A. Phipps, M.A. Sabourin, W. Buckingham, and L. Strunin. Detection of picogram concentrations of fentanyl in plasma by gas-liquid chromatography. J. Chromatogr. 272: 392-95 (1983).
36. ST. Weldon, D.F. Perry, R.C. Cork, and A.J. Gandolfi. Detection of picogram levels of sufentanil by capillary gas chromatography. Anesthesiology 63: 684-87 (1985).
37. M.T. Cheng, G.H. Kruppa, F.W. McLafferty, and DA. Cooper. Structural information from tandem mass spectrometry for China White and related fentanyl derivatives. Anal. Chem. 54: 2204-2207 (1982).
38. R.A. Sams and L. Malspeis. Determination of naloxone and naltrexone as perfluoroalkyl ester derivatives by electron-capture gas-liquid chromatography. J. Chromatogr. 125: 409-20 (1976).
39. K.-C. Low and A.M. Duffield. A site specific rearrangement in electron capture negative ion Ci mass spectrometry of pentafluoropro-pionyl derivatives of some β-hydroxyamines. Biomed. Mass Spectrom. 11: 77-181 (1984).
40. T. Krishnamurthy and E.W. Sarver. Mass spectral investigations on trichothecene mycotoxins; III. Synthesis, characterization and applications of pentafluoropropionyl and trifluoroacetyl esters of simple trichothecenes. J. Chromatogr. 355: 253-64 (1986).
41. E. Anggard and G. Sedvall. Gas chromatography of catecholamine metabolites using electron capture detection and spectrometry. Anal. Chem. 41: 1250-56 (1969).
42. E. Gelpi. Gas-chromatography-mass spectrometry and selected ion monitoring of biogenic amines and related metabolites. In Analysis of Biogenic Amines, Part A, G.B. Baker and R.T. Courts, Eds. Elsevier Scientific Publishing Co., Amsterdam, 1982, pp. 151-79.
43. A.C. Tas, J. Odink, M.C.T.N. de Brauw, J. Schrivjer, and R.J.G. Jonk. Derivatization and mass spectrometric behavior of catecholamines and their O-3-methylated metabolites. J. Chromatogr. 310:243-50 (1984).
44. S.H. Koslow, F. Cattabeni, and E. Costa. Norepinephrine and dopamine: Assay by mass fragmentography in the picomole range. Science 176: 77-180 (1972).
45. F. Zambotti, K. Blau, G.S. King, S. Campbell, and M. Sandler. Monoamine metabolites and related compounds in human amniotic fluid: Assay by gas chromatography and gas chromatog-raphy-mass spectrometry. Clin. Chim. Acta 61: 247-56 (1975).
46. FT. Delbeke, M. Debackere, J.A.A. Jonckheere, and A.P. DeLeenheer. Pentafluorobenzoyl derivatives of doping agents; I. Extractive benzoylation and gas-chromatography with electron-capture detection of primary and secondary amines. J. Chromatogr. 273: 141-49 (1983).
47. O. Beck and K.F. Faull. Extractive acylation and mass spectrometric assay of 3-methoxytyramine, normetanephrine, and metanephrine in cerebrospinal fluid. Anal. Biochem. 149: 492-500 (1985).
48. G.B. Baker, T.S. Rau, and R.T. Courts. Electron-capture gas chromatographic analysis of β-phenylethylamine in tissue and body fluids using pentafluorobenzenesulfonyl chloride for derivatization. J. Chromatogr. 381: 211-17 (1986).
49. J.M. Yeung, G.B. Baker, and R.T. Courts. Simple automated gas chromatographic analysis of amino acids and its application to brain tissue and urine. J. Chromatogr. 378: 293-304 (1986).
50. S.D. Roy, G. McKay, EM. Hawes, and K.K. Midha. Gas chromatographic quantitation of methoxyphenamine and three of its metabolites in plasma. J. Chromatogr. 310: 307-17 (1984).